Does angiotensin blockade influence graft outcome in renal transplant recipients with IgA nephropathy?

Nephrology Dialysis Transplantation

Volumn 21, Issue 12, 2006, Pages 3550-3554

  Courtney, Aisling E ^a   McNamee, Peter T ^a   Nelson, William E ^a   Maxwell, Alexander Peter ^a  

^a BELFAST CITY HOSPITAL   (United Kingdom)

Author keywords

IgA nephropathy; Recurrent glomerulonephritis; Renal transplantation; Renin Angiotensin system

Indexed keywords

ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; ANGIOTENSIN; ANGIOTENSIN 2 RECEPTOR ANTAGONIST; ANGIOTENSIN ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCINEURIN INHIBITOR; CALCIUM ANTAGONIST; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; STEROID;

ADULT; ARTICLE; CONTROLLED STUDY; DEMOGRAPHY; FEMALE; FOLLOW UP; GRAFT RECIPIENT; GRAFT SURVIVAL; HUMAN; IMMUNOGLOBULIN A NEPHROPATHY; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY BIOPSY; KIDNEY FAILURE; KIDNEY TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PRESCRIPTION; PRIORITY JOURNAL; RECEPTOR BLOCKING; RECURRENT DISEASE; STATISTICAL SIGNIFICANCE; SURVIVAL TIME; TREATMENT DURATION; UNITED KINGDOM; UNSPECIFIED SIDE EFFECT;

ADULT; ANGIOTENSIN II TYPE 1 RECEPTOR BLOCKERS; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; FEMALE; GLOMERULONEPHRITIS, IGA; HUMANS; KIDNEY FAILURE, CHRONIC; KIDNEY TRANSPLANTATION; MALE; RECURRENCE; RETROSPECTIVE STUDIES;

EID: 33751433117     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfl506     Document Type: Article

References (20)

1. Levy M, Berger J. Worldwide perspective of IgA nephropathy. Am J Kidney Dis 1988; 12: 340-347
2. Odum J, Peh CA, Clarkson AR et al. Recurrent mesangial IgA nephritis following renal transplantation. Nephrol Dial Transplant 1994; 9: 309-312
3. Berger J. Recurrence of IgA nephropathy in renal allografts. Am J Kidney Dis 1988; 12: 371-372
4. Bumgardner GL, Amend WC, Ascher NL, Vincenti FG. Single-center long-term results of renal transplantation for IgA nephropathy. Transplantation 1998; 65: 1053-1060
5. Choy BY, Chan TM, Lo SK, Lo WK, Lai KN. Renal transplantation in patients with primary immunoglobulin A nephropathy. Nephrol Dial Transplant 2003; 18: 2399-2404
6. Floege J. Recurrent IgA nephropathy after renal transplantation. Semin Nephrol 2004; 24: 287-291
7. Ohmacht C, Kliem V, Burg M et al. Recurrent immunoglobulin A nephropathy after renal transplantation: A significant contributor to graft loss. Transplantation 1997; 64: 1493-1496
8. Ponticelli C, Traversi L, Feliciani A, Cesana BM, Banfi G, Tarantino A. Kidney transplantation in patients with IgA mesangial glomerulonephritis. Kidney Int 2001; 60: 1948-1954
9. Briganti EM, Russ GR, McNeil JJ, Atkins RC, Chadban SJ. Risk of renal allograft loss from recurrent glomerulonephritis. N Engl J Med 2002; 347: 103-109
10. European best practice guidelines for renal transplantation. Section IV: long-term management of the transplant recipient. IV.2.5. Chronic graft dysfunction. Late recurrence of primary glomerulonephritides. Nephrol Dial Transplant 2002; 17 [Suppl 4]: 16-18
11. Agodoa L, Eknoyan G, Ingelfinger J et al. Assessment of structure and function in progressive renal disease. Kidney Int Suppl 1997; 63: S144-S150
12. Nakao N, Yoshimura A, Morita H, Takada M, Kayano T, Ideura T. Combination treatment of angiotensin-II receptor blocker and angiotensin-converting-enzyme inhibitor in non-diabetic renal disease (COOPERATE): A randomised controlled trial. Lancet 2003; 361: 117-124
13. Brenner BM, Zagrobelny J. Clinical renoprotection trials involving angiotensin II-receptor antagonists and angiotensin-converting-enzyme inhibitors. Kidney Int Suppl 2003; 83: S77-85
14. Kimata N, Tanabe K, Ishikawa N et al. Correlation between proteinuria and prognosis of transplant IgA nephropathy. Transplant Proc 1996; 28: 1537-1539
15. Oka K, Imai E, Moriyama T et al. A clinicopathological study of IgA nephropathy in renal transplant recipients: Beneficial effect of angiotensin-converting enzyme inhibitor. Nephrol Dial Transplant 2000; 15: 689-695
16. Jennette JC. The immunohistology of IgA nephropathy. Am J Kidney Dis 1988; 12: 348-352
17. Opelz G, Wujciak T, Ritz E. Association of chronic kidney graft failure with recipient blood pressure. Collaborative Transplant Study. Kidney Int 1998; 53: 217-222
18. Artz MA, Hilbrands LB, Borm G, Assmann KJ, Wetzels JF. Blockade of the renin-angiotensin system increases graft survival in patients with chronic allograft nephropathy. Nephrol Dial Transplant 2004; 19: 2852-2857
19. Chandrakantan A, Ratanapanichkich P, Said M, Barker CV, Julian BA. Recurrent IgA nephropathy after renal transplantation despite immunosuppressive regimens with mycophenolate mofetil. Nephrol Dial Transplant 2005; 20: 1214-1221
20. Kasiske BL, Guijarro C, Massy ZA, Wiederkehr MR, Ma JZ. Cardiovascular disease after renal transplantation. J Am Soc Nephrol 1996; 7: 158-165